{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:18:42Z","timestamp":1785352722701,"version":"3.55.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>The significant heterogeneity in treatment responses among patients with acute myeloid leukemia (AML) underscores the critical need for accurate drug response prediction. We developed k-Top Scoring Pairs (kTSP) classifiers, ensemble methods that aggregate the relative expression of gene pairs. We compared their accuracy with that of state-of-the-art machine learning methods, linear and radial basis function support vector machines, random forest and elastic net regression classifiers for drug response prediction of patients with AML. Our results demonstrate that kTSP particularly outperforms other methods when the number of sensitive and resistant patients is imbalanced, a common challenge in clinical studies. Our approach is inherently robust to batch effects and uniquely suited for single-patient classification due to its rank-based methodology.<\/jats:p>","DOI":"10.1371\/journal.pone.0343422","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:38:39Z","timestamp":1771871919000},"page":"e0343422","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Robust predictors for drug response of patients with acute myeloid leukemia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-264X","authenticated-orcid":true,"given":"Bahar","family":"Tercan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"12","key":"pone.0343422.ref001","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"H D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"pone.0343422.ref002","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/nrdp.2016.10","article-title":"Acute myeloid leukaemia","volume":"2","author":"A Khwaja","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0343422.ref003"},{"issue":"5","key":"pone.0343422.ref004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation","volume":"377","author":"RM Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0343422.ref005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/bloodadvances.2016003053","article-title":"A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001","volume":"1","author":"GL Uy","year":"2017","journal-title":"Blood Adv"},{"issue":"14","key":"pone.0343422.ref006","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-17-3179","article-title":"FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia","volume":"24","author":"EY Jen","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"30","key":"pone.0343422.ref007","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2217\/fon-2018-0325","article-title":"Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia","volume":"14","author":"M Gbadamosi","year":"2018","journal-title":"Future Oncol"},{"issue":"22","key":"pone.0343422.ref008","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.3390\/cancers13225722","article-title":"Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives","volume":"13","author":"M Fleischmann","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"pone.0343422.ref009","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/s41591-020-1089-8","article-title":"Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial","volume":"26","author":"A Burd","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"pone.0343422.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"D Bottomly","year":"2022","journal-title":"Cancer Cell"},{"issue":"7728","key":"pone.0343422.ref011","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"JW Tyner","year":"2018","journal-title":"Nature"},{"key":"pone.0343422.ref012","doi-asserted-by":"crossref","first-page":"108432","DOI":"10.1016\/j.cmpb.2024.108432","article-title":"Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach","volume":"257","author":"N Karathanasis","year":"2024","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"pone.0343422.ref013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41698-023-00374-z","article-title":"Prediction model for drug response of acute myeloid leukemia patients","volume":"7","author":"QT Trac","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"pone.0343422.ref014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41698-024-00596-9","article-title":"A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML","volume":"8","author":"EO Karakaslar","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"pone.0343422.ref015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-022-01115-w","article-title":"Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment","volume":"14","author":"C Lee","year":"2022","journal-title":"Genome Med"},{"key":"pone.0343422.ref016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.leukres.2018.11.010","article-title":"Predicting response to BET inhibitors using computational modeling: A BEAT AML project study","volume":"77","author":"LM Drusbosky","year":"2019","journal-title":"Leuk Res"},{"issue":"1","key":"pone.0343422.ref017","doi-asserted-by":"crossref","first-page":"101359","DOI":"10.1016\/j.xcrm.2023.101359","article-title":"Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia","volume":"5","author":"JC Pino","year":"2024","journal-title":"Cell Rep Med"},{"issue":"1","key":"pone.0343422.ref018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-022-09367-9","article-title":"Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML","volume":"19","author":"SJC Gosline","year":"2022","journal-title":"Clin Proteomics"},{"issue":"20","key":"pone.0343422.ref019","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/bioinformatics\/bti631","article-title":"Simple decision rules for classifying human cancers from gene expression profiles","volume":"21","author":"AC Tan","year":"2005","journal-title":"Bioinformatics"},{"issue":"6","key":"pone.0343422.ref020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/2643-3230.BCD-23-0014","article-title":"Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy","volume":"4","author":"CA Eide","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"pone.0343422.ref021","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","article-title":"Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia","volume":"12","author":"D Malani","year":"2022","journal-title":"Cancer Discov"},{"issue":"8","key":"pone.0343422.ref022","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1261\/rna.074922.120","article-title":"Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols","volume":"26","author":"S Zhao","year":"2020","journal-title":"RNA"},{"key":"pone.0343422.ref023","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1071","article-title":"Classifying gene expression profiles from pairwise mRNA comparisons","volume":"3","author":"D Geman","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"2","key":"pone.0343422.ref024","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/bioinformatics\/btu622","article-title":"switchBox: an R package for k-Top Scoring Pairs classifier development","volume":"31","author":"B Afsari","year":"2015","journal-title":"Bioinformatics"},{"key":"pone.0343422.ref025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/1471-2164-14-336","article-title":"A simple and reproducible breast cancer prognostic test","volume":"14","author":"L Marchionni","year":"2013","journal-title":"BMC Genomics"},{"key":"pone.0343422.ref026","doi-asserted-by":"crossref","unstructured":"Afsari B, Braga-Neto UM, Geman D. Rank discriminants for predicting phenotypes from RNA expression. 2014. https:\/\/hdl.handle.net\/1969.1\/184776","DOI":"10.1214\/14-AOAS738"},{"issue":"36","key":"pone.0343422.ref027","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1703094114","article-title":"Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies","volume":"114","author":"SE Kurtz","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0343422.ref028","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41596-023-00903-x","article-title":"Robust scoring of selective drug responses for patient-tailored therapy selection","volume":"19","author":"Y Chen","year":"2024","journal-title":"Nat Protoc"},{"key":"pone.0343422.ref029","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies","volume":"4","author":"B Yadav","year":"2014","journal-title":"Sci Rep"},{"key":"pone.0343422.ref030","first-page":"39","article-title":"Support Vector Machines for Classification","author":"M Awad","year":"2015","journal-title":"Efficient Learning Machines"},{"key":"pone.0343422.ref031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10408340600969486","article-title":"Support Vector Machines: A Recent Method for Classification in Chemometrics","volume":"36","author":"Y Xu","year":"2006","journal-title":"Critical Reviews in Analytical Chemistry"},{"key":"pone.0343422.ref032","volume-title":"The nature of statistical learning theory","author":"VNA Vapnik","year":"2010"},{"issue":"1","key":"pone.0343422.ref033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"L Breiman","year":"2001","journal-title":"Machine Learning"},{"issue":"2","key":"pone.0343422.ref034","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and Variable Selection Via the Elastic Net","volume":"67","author":"H Zou","year":"2005","journal-title":"Journal of the Royal Statistical Society Series B: Statistical Methodology"},{"key":"pone.0343422.ref035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: Synthetic Minority Over-sampling Technique","volume":"16","author":"NV Chawla","year":"2002","journal-title":"jair"},{"issue":"1","key":"pone.0343422.ref036","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40364-024-00705-7","article-title":"The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications","volume":"12","author":"A Hodges","year":"2024","journal-title":"Biomark Res"},{"issue":"4","key":"pone.0343422.ref037","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cyto.b.21952","article-title":"Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation","volume":"100","author":"HRO Churchill","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"33","key":"pone.0343422.ref038","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41388-025-03464-3","article-title":"MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation","volume":"44","author":"J Liu","year":"2025","journal-title":"Oncogene"},{"issue":"6","key":"pone.0343422.ref039","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.36","article-title":"Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets","volume":"6","author":"A Maiga","year":"2016","journal-title":"Blood Cancer J"},{"issue":"7","key":"pone.0343422.ref040","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204037","article-title":"Identification of survival-related alternative splicing signatures in acute myeloid leukemia","volume":"41","author":"B Zhang","year":"2021","journal-title":"Biosci Rep"},{"issue":"9","key":"pone.0343422.ref041","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0611373104","article-title":"Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas","volume":"104","author":"ND Price","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"pone.0343422.ref042","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/bioinformatics\/btab088","article-title":"multiclassPairs: an R package to train multiclass pair-based classifier","volume":"37","author":"N-A-D Marzouka","year":"2021","journal-title":"Bioinformatics"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:38:45Z","timestamp":1771871925000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343422"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343422","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]}}}